Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers
Clinical trial NCT02392468 · COMPLETED
Trial details
- NCT number
- NCT02392468
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-15
- Primary completion
- 2017-08-03
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.